{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:21:16Z","timestamp":1787671276740,"version":"build-2736575974"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1908D"],"award-info":[{"award-number":["01GM1908D"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["HIL-A03 BaoBab"],"award-info":[{"award-number":["HIL-A03 BaoBab"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["PR1274\/9-1"],"award-info":[{"award-number":["PR1274\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["FOR3004"],"award-info":[{"award-number":["FOR3004"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["PR1274\/5-1"],"award-info":[{"award-number":["PR1274\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.smim.2025.101955","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:54:08Z","timestamp":1745326448000},"page":"101955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["From immunobiology to intervention: Pathophysiology of autoimmune encephalitis"],"prefix":"10.1016","volume":"78","author":[{"given":"Marie A.","family":"Homeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-7976","authenticated-orcid":false,"given":"Harald","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann. Neurol."},{"issue":"9451","key":"10.1016\/j.smim.2025.101955_bib2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.smim.2025.101955_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13405","article-title":"Antibodies in neurological diseases: established, emerging, explorative","author":"Li","year":"2024","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib5","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001088","article-title":"Network for research on autoimmune, rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib7","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"issue":"Pt 10","key":"10.1016\/j.smim.2025.101955_bib8","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.smim.2025.101955_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbi.2024.08.027","article-title":"Human cerebrospinal fluid monoclonal CASPR2 autoantibodies induce changes in electrophysiology, functional MRI, and behavior in rodent models","volume":"122","author":"van Hoof","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.smim.2025.101955_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ana.26345","article-title":"Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex","author":"Joubert","year":"2022","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.smim.2025.101955_bib11","article-title":"Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures","volume":"218","author":"Kreye","year":"2021","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib12","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI122942","article-title":"Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica","volume":"129","author":"Soltys","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib13","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/brain\/awae129","article-title":"Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo","volume":"147","author":"Upadhya","year":"2024","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.smim.2025.101955_bib14","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/brain\/awz119","article-title":"Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies","volume":"142","author":"Giannoccaro","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.smim.2025.101955_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114838","article-title":"Memory loss and aberrant neurogenesis in mice exposed to patient anti-N-methyl-d-aspartate receptor antibodies","volume":"378","author":"Taraschenko","year":"2024","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/epi.14662","article-title":"A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis","volume":"60","author":"Taraschenko","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.smim.2025.101955_bib17","article-title":"Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis","author":"Maudes","year":"2024","journal-title":"Brain"},{"issue":"500","key":"10.1016\/j.smim.2025.101955_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0044","article-title":"Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors","volume":"11","author":"Jones","year":"2019","journal-title":"Sci. Transl. Med"},{"issue":"12","key":"10.1016\/j.smim.2025.101955_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210109","article-title":"Long-Term Cognitive, Functional, and Patient-Reported Outcomes in Patients With Anti-NMDAR Encephalitis","volume":"103","author":"Brenner","year":"2024","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib20","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200108","article-title":"Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis","volume":"10","author":"Ciano-Petersen","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101955_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-020-0381-z","article-title":"The B cell immunobiology that underlies CNS autoantibody-mediated diseases","author":"Sun","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.smim.2025.101955_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-323-90820-7.00005-7","article-title":"Autoantibody-mediated central nervous system channelopathies","volume":"203","author":"Binks","year":"2024","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molmed.2022.09.011","article-title":"Molecular disease mechanisms of human antineuronal monoclonal autoantibodies","volume":"29","author":"Duong","year":"2023","journal-title":"Trends Mol. Med"},{"issue":"7042","key":"10.1016\/j.smim.2025.101955_bib24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nature03724","article-title":"Cellular and genetic mechanisms of self tolerance and autoimmunity","volume":"435","author":"Goodnow","year":"2005","journal-title":"Nature"},{"issue":"5638","key":"10.1016\/j.smim.2025.101955_bib25","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.25460","article-title":"N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit","volume":"85","author":"Wenke","year":"2019","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.smim.2025.101955_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311049121","article-title":"Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis","volume":"121","author":"Theorell","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2025.101955_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2024.05.034","article-title":"Antibody-secreting cells as a source of NR1-IgGs in N-methyl-D-aspartate receptor-antibody encephalitis","volume":"120","author":"Qing Li","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.smim.2025.101955_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal Centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40478-019-0693-7","article-title":"Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis","volume":"7","author":"Chefdeville","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.smim.2025.101955_bib31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PAS.0000000000001249","article-title":"Ovarian Teratomas in Women With Anti-N-methyl-D-Aspartate Receptor Encephalitis: Topography and Composition of Immune Cell and Neuroglial Populations Is Compatible With an Autoimmune Mechanism of Disease","volume":"43","author":"Nolan","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib32","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/brain\/awac088","article-title":"Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis","volume":"145","author":"Al-Diwani","year":"2022","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.immuni.2021.03.013","article-title":"Positive selection of IgG(+) over IgM(+) B cells in the germinal center reaction","volume":"54","author":"Sundling","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"Tuzun","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/brain\/awaa104","article-title":"Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms","volume":"143","author":"Ramberger","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"G. Faciobrachial Dystonic Seizures Study, The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ana.25666","article-title":"Human Cerebrospinal Fluid Monoclonal LGI1 Autoantibodies Increase Neuronal Excitability","volume":"87","author":"Kornau","year":"2020","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.smim.2025.101955_bib39","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1007\/s00415-024-12594-9","article-title":"LGI1 encephalitis: potentially complement-activating anti-LGI1-IgG subclasses 1\/2\/3 are associated with the development of hippocampal sclerosis","volume":"271","author":"Bien","year":"2024","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.smim.2025.101955_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1916337118","article-title":"Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA(A) receptor encephalitis","volume":"118","author":"Brandle","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2025.101955_bib41","doi-asserted-by":"crossref","first-page":"1376456","DOI":"10.3389\/fimmu.2024.1376456","article-title":"HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease","volume":"15","author":"Koneczny","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.25173","article-title":"N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib44","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000669","article-title":"Intrathecal B-cell activation in LGI1 antibody encephalitis","volume":"7","author":"Lehmann-Horn","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","article-title":"Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)","volume":"102","author":"Revy","year":"2000","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib46","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib48","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ana.25216","article-title":"E. German Network for Research on Autoimmune, Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2019.07.001","article-title":"Class-Switch Recombination Occurs Infrequently in Germinal Centers","volume":"51","author":"Roco","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2015.06.013","article-title":"Salmonella Infection Drives Promiscuous B Cell Activation Followed by Extrafollicular Affinity Maturation","volume":"43","author":"Niro","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/imr.12741","article-title":"Extrafollicular responses in humans and SLE","volume":"288","author":"Jenks","year":"2019","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib53","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","article-title":"Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity","volume":"53","author":"Elsner","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2025.101955_bib54","first-page":"109","article-title":"Germinal center versus extrafollicular responses in systemic autoimmunity: Who turns the blade on self?","volume":"162","author":"He","year":"2024","journal-title":"Adv. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib55","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00415-020-10371-y","article-title":"Decreased inflammatory cytokine production of antigen-specific CD4(+) T cells in NMDA receptor encephalitis","volume":"268","author":"Dao","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.smim.2025.101955_bib56","doi-asserted-by":"crossref","first-page":"1021370","DOI":"10.3389\/fimmu.2022.1021370","article-title":"The extrafollicular response is sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus","volume":"13","author":"Voss","year":"2022","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/pcn.13627","article-title":"Single-cell RNA sequencing reveals diverse B cell phenotypes in patients with anti-NMDAR encephalitis","volume":"78","author":"Li","year":"2024","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib58","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41590-019-0419-9","article-title":"Epigenetic programming underpins B cell dysfunction in human SLE","volume":"20","author":"Scharer","year":"2019","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.smim.2025.101955_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102604","article-title":"The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity","volume":"47","author":"Yu","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.smim.2025.101955_bib62","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis","volume":"10","author":"Blinder","year":"2019","journal-title":"Front Neurol."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib63","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001086","article-title":"Network for Research on Autoimmune, CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis","volume":"8","author":"Durr","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38462-6","article-title":"The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis","volume":"13","author":"Hummert","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib65","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/acn3.561","article-title":"Elevated LGI1-IgG CSF index predicts worse neurological outcome","volume":"5","author":"Gadoth","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib66","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ana.26223","article-title":"Neuropathological Variability within a Spectrum of NMDAR-Encephalitis","volume":"90","author":"Zrzavy","year":"2021","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib67","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001137","article-title":"Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease: A Case Series","volume":"9","author":"Strippel","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib68","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000232","article-title":"Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis","volume":"3","author":"Golombeck","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/acn3.50974","article-title":"An expanded parenchymal CD8+\u2009T cell clone in GABA(A) receptor encephalitis","volume":"7","author":"Bracher","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7560","key":"10.1016\/j.smim.2025.101955_bib70","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.smim.2025.101955_bib71","article-title":"Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases-A Comprehensive Review","volume":"11","author":"Ruschil","year":"2021","journal-title":"Diagn. (Basel)"},{"issue":"248","key":"10.1016\/j.smim.2025.101955_bib72","doi-asserted-by":"crossref","first-page":"248ra107","DOI":"10.1126\/scitranslmed.3008879","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6","author":"Stern","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.smim.2025.101955_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaf096","article-title":"E.M.C.A.I.E.S.g. in cooperation with the, Activated alphabeta T- and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis","author":"Esser","year":"2025","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161656","article-title":"Utility of CSF Cytokine\/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2025.101955_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2016.05.023","article-title":"Distinct intrathecal interleukin-17\/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis","volume":"297","author":"Byun","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12974-016-0507-9","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid","volume":"13","author":"Liba","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib77","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib78","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000460","article-title":"Regulated Production of CXCL13 within the Central Nervous System","volume":"7","author":"Irani","year":"2016","journal-title":"J. Clin. Cell Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib79","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.20181216","article-title":"Type I interferon induces CXCL13 to support ectopic germinal center formation","volume":"216","author":"Denton","year":"2019","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2025.101955_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"Kowarik","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101955_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155226","article-title":"Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis","volume":"135","author":"Kortvelyessy","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.smim.2025.101955_bib82","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.2147\/NDT.S222258","article-title":"CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients","volume":"15","author":"Lin","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib83","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10875-012-9709-9","article-title":"Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse","volume":"32","author":"Wang","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101955_bib84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2017.01.012","article-title":"Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome","volume":"305","author":"Deng","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"626","key":"10.1016\/j.smim.2025.101955_bib85","doi-asserted-by":"crossref","first-page":"eabj0473","DOI":"10.1126\/scitranslmed.abj0473","article-title":"DICAM promotes T(H)17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation","volume":"14","author":"Charabati","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152340","article-title":"Deregulated phenotype of autoreactive Th17 and Treg clone cells in pemphigus vulgaris after in-vitro treatment with desmoglein antigen (Dsg-3)","volume":"228","author":"Ansari","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.smim.2025.101955_bib87","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib88","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/ane.12850","article-title":"The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis","volume":"137","author":"Ai","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.smim.2025.101955_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.582296","article-title":"Cytokines\/Chemokines: Potential Biomarkers for Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Neurol."},{"issue":"12","key":"10.1016\/j.smim.2025.101955_bib90","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/abbs\/gmy137","article-title":"Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis","volume":"50","author":"Zeng","year":"2018","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1354","article-title":"Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis","volume":"9","author":"Li","year":"2019","journal-title":"Brain Behav."},{"key":"10.1016\/j.smim.2025.101955_bib92","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3389\/fimmu.2019.00905","article-title":"Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis","volume":"10","author":"Peng","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib93","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2025.101955_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.673021","article-title":"Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis","volume":"12","author":"Levraut","year":"2021","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib95","doi-asserted-by":"crossref","first-page":"fcac196","DOI":"10.1093\/braincomms\/fcac196","article-title":"Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis","volume":"4","author":"Ciano-Petersen","year":"2022","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib96","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1212\/01.wnl.0000223647.83708.20","article-title":"Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis","volume":"67","author":"Blumenthal","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","article-title":"Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis","volume":"103","author":"Bernal","year":"2002","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib98","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1468-1331.2010.03180.x","article-title":"Brain immunohistopathological study in a patient with anti-NMDAR encephalitis","volume":"18","author":"Camdessanche","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib99","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"7604","key":"10.1016\/j.smim.2025.101955_bib100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature17979","article-title":"Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help","volume":"533","author":"Iijima","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.47936\/encephalitis.2022.00052","article-title":"Regulatory T cell profiles in patients with N-methyl-\u1d05-aspartate receptor-antibody encephalitis","volume":"3","author":"Iro","year":"2023","journal-title":"Encephalitis"},{"issue":"11","key":"10.1016\/j.smim.2025.101955_bib102","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nri3086","article-title":"Microglial cell origin and phenotypes in health and disease","volume":"11","author":"Saijo","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib103","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbadis.2015.10.026","article-title":"Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation","volume":"1862","author":"Kaminska","year":"2016","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib104","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12974-023-02841-7","article-title":"Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood\u2212brain barrier disruption in anti-NMDA receptor encephalitis","volume":"20","author":"Chang","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib105","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/glia.24369","article-title":"Microglia actively remove NR1 autoantibody-bound NMDA receptors and associated post-synaptic proteins in neuron microglia co-cultures","volume":"71","author":"Rahman","year":"2023","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib106","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamaneurol.2014.488","article-title":"Abnormal neurons in teratomas in NMDAR encephalitis","volume":"71","author":"Day","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/acn3.51948","article-title":"Teratoma pathology and genomics in anti-NMDA receptor encephalitis","volume":"11","author":"Jang","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib108","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/ene.14596","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations","volume":"28","author":"Shu","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001053","article-title":"Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies","volume":"8","author":"Guasp","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188730","article-title":"Recent thymic emigrants as the bridge between thymoma and autoimmune diseases","volume":"1877","author":"Ao","year":"2022","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"9","key":"10.1016\/j.smim.2025.101955_bib112","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.smim.2025.101955_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577804","article-title":"Comparison of the clinical syndromes of anti-GABAa versus anti-GABAb associated autoimmune encephalitis: A systematic review","volume":"363","author":"Ronchi","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"24","key":"10.1016\/j.smim.2025.101955_bib114","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients","volume":"84","author":"Hoftberger","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib115","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib116","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s13311-020-00921-7","article-title":"Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis","volume":"18","author":"Lee","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib117","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat. Med"},{"issue":"9","key":"10.1016\/j.smim.2025.101955_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12091953","article-title":"Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges","volume":"12","author":"Sogaard","year":"2024","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.smim.2025.101955_bib119","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Simplex Encephalitis Study, Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib120","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000537","article-title":"Anti-NMDAR encephalitis with concomitant varicella zoster virus detection and nonteratomatous malignancy","volume":"6","author":"Prakash","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101955_bib121","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2018.05.003","article-title":"An anti-NMDA receptor encephalitis mimicking an HIV encephalitis","volume":"193","author":"Haneche","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101955_bib122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pediatrneurol.2017.03.010","article-title":"Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series","volume":"72","author":"Goenka","year":"2017","journal-title":"Pedia Neurol."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib123","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0038-1675607","article-title":"Japanese Encephalitis Virus-Induced Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of Literature","volume":"50","author":"Tian","year":"2019","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.smim.2025.101955_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2019.03.011","article-title":"Anti-NMDAR encephalitis preceded by non-herpetic central nervous system infection: Systematic literature review and first case of tick-borne encephalitis triggering anti-NMDAR encephalitis","volume":"332","author":"Cavaliere","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.smim.2025.101955_bib125","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABA(A) receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mds.25623","article-title":"Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor","volume":"29","author":"Mohammad","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.smim.2025.101955_bib127","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jtbi.2014.08.034","article-title":"Molecular mimicry and clonal deletion: A fresh look","volume":"375","author":"Rose","year":"2015","journal-title":"J. Theor. Biol."},{"issue":"7900","key":"10.1016\/j.smim.2025.101955_bib128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.smim.2025.101955_bib129","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.tim.2020.03.003","article-title":"Herpes Simplex Virus-1 in the Brain: The Dark Side of a Sneaky Infection","volume":"28","author":"Marcocci","year":"2020","journal-title":"Trends Microbiol"},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib130","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1158\/2326-6066.CIR-19-0870","article-title":"Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention","volume":"8","author":"Jacqueline","year":"2020","journal-title":"Cancer Immunol. Res"},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrmicro3415","article-title":"Pathogen manipulation of B cells: the best defence is a good offence","volume":"13","author":"Nothelfer","year":"2015","journal-title":"Nat. Rev. Microbiol"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib132","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol"},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib133","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001062","article-title":"Intrathecal antibody production against epstein-barr, herpes simplex, and other neurotropic viruses in autoimmune encephalitis","volume":"8","author":"Schwenkenbecher","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib134","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40120-022-00330-2","article-title":"Intrathecally expanding B cell clones in herpes simplex encephalitis: a case report","volume":"11","author":"Coronel-Castello","year":"2022","journal-title":"Neurol. Ther."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri.2017.143","article-title":"HLA variation and disease","volume":"18","author":"Dendrou","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2025.101955_bib136","article-title":"The Protective Role of HLA-DRB1( *)13 in Autoimmune Diseases","author":"Bettencourt","year":"2015","journal-title":"J. Immunol. Res 2015"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib137","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1038\/s41598-022-13042-2","article-title":"A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity","volume":"12","author":"Panhuber","year":"2022","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib138","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.smim.2025.101955_bib139","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1093\/brain\/awae048","article-title":"HLA-DQB1*\u200905 subtypes and not DRB1*\u200910:01 mediates risk in anti-IgLON5 disease","volume":"147","author":"Yogeshwar","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.smim.2025.101955_bib140","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200221","article-title":"Genome-Wide Association Study Identifies IFIH1 and HLA-DQB1*05:02 Loci Associated With Anti-NMDAR Encephalitis","volume":"11","author":"Liu","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib141","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp-2018-319714","article-title":"HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis","volume":"90","author":"Shu","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.smim.2025.101955_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577243","article-title":"Novel findings of HLA association with anti-LGI1 encephalitis: HLA-DRB1*\u200903:01 and HLA-DQB1*\u200902:01","volume":"344","author":"Hu","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2025.101955_bib143","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pediatrneurol.2022.06.014","article-title":"HLA-DRB1 *\u20091502 Is Associated With Anti-N-Methyl-D-aspartate Receptor Encephalitis in Thai Children","volume":"134","author":"Anurat","year":"2022","journal-title":"Pedia Neurol."},{"issue":"12","key":"10.1016\/j.smim.2025.101955_bib144","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41590-021-01058-1","article-title":"Human immune diversity: from evolution to modernity","volume":"22","author":"Liston","year":"2021","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41435-023-00213-y","article-title":"The dynamic interface of genetics and immunity: toward future horizons in health & disease","volume":"24","author":"Garg","year":"2023","journal-title":"Genes Immun."},{"key":"10.1016\/j.smim.2025.101955_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889296","article-title":"Construction and Application of Polygenic Risk Scores in Autoimmune Diseases","volume":"13","author":"Khunsriraksakul","year":"2022","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib147","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001085","article-title":"Network for Research on Autoimmune, Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis","volume":"8","author":"Tietz","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.smim.2025.101955_bib148","article-title":"Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohorts","author":"Binks","year":"2024","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib149","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208019","article-title":"Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis","volume":"102","author":"Morgan","year":"2024","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.smim.2025.101955_bib150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"N. Autoimmune Encephalitis Alliance Clinicians, Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib151","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/dmcn.12036","article-title":"Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis","volume":"55","author":"Dale","year":"2013","journal-title":"Dev. Med Child Neurol."},{"issue":"11","key":"10.1016\/j.smim.2025.101955_bib152","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","article-title":"Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis","volume":"78","author":"Nosadini","year":"2021","journal-title":"JAMA Neurol."},{"issue":"22","key":"10.1016\/j.smim.2025.101955_bib153","doi-asserted-by":"crossref","first-page":"e2300","DOI":"10.1212\/WNL.0000000000207746","article-title":"Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis","volume":"101","author":"Yang","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib154","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI83840","article-title":"Rituximab does not reset defective early B cell tolerance checkpoints","volume":"126","author":"Chamberlain","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.smim.2025.101955_bib155","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2024-225727","article-title":"B-cell depletion in autoimmune diseases","author":"Schett","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"10206","key":"10.1016\/j.smim.2025.101955_bib156","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","article-title":"Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2\/3 trial","volume":"394","author":"Cree","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.smim.2025.101955_bib157","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","article-title":"Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus","volume":"383","author":"Ostendorf","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"10","key":"10.1016\/j.smim.2025.101955_bib158","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/bloodadvances.2019001091","article-title":"Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+\u2009T-cell responses","volume":"4","author":"Manna","year":"2020","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib159","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1111\/ene.15266","article-title":"Daratumumab for treatment-refractory antibody-mediated diseases in neurology","volume":"29","author":"Scheibe","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.smim.2025.101955_bib160","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","article-title":"The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus","volume":"74","author":"Alexander","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib161","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/eji.1830160206","article-title":"Limiting dilution analysis of the B cell compartment in human bone marrow","volume":"16","author":"Hibi","year":"1986","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2025.101955_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577586","article-title":"Bortezomib in anti-N-Methyl-d-Aspartate-Receptor (NMDA-R) encephalitis: A systematic review","volume":"356","author":"Dinoto","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib163","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s13063-020-04516-7","article-title":"Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis","volume":"21","author":"Wickel","year":"2020","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib164","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ene.15585","article-title":"Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell-depleting escalation therapies for treatment-refractory patients","volume":"30","author":"Schwarz","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"24","key":"10.1016\/j.smim.2025.101955_bib165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121804119","article-title":"Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders","volume":"119","author":"Damato","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib166","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/ard-2024-226142","article-title":"CD19-CAR T-cell therapy induces deep tissue depletion of B cells","volume":"84","author":"Tur","year":"2025","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.smim.2025.101955_bib167","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1007\/s00415-024-12642-4","article-title":"Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature review","volume":"271","author":"Konitsioti","year":"2024","journal-title":"J. Neurol."},{"issue":"10468","key":"10.1016\/j.smim.2025.101955_bib168","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/S0140-6736(24)02265-7","article-title":"Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells","volume":"404","author":"Hagen","year":"2024","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.smim.2025.101955_bib169","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403227121","article-title":"Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome","volume":"121","author":"Faissner","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40291-023-00673-y","article-title":"Equecabtagene autoleucel: first approval","volume":"27","author":"Keam","year":"2023","journal-title":"Mol. Diagn. Ther."},{"issue":"1","key":"10.1016\/j.smim.2025.101955_bib171","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-022-01278-3","article-title":"Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results","volume":"8","author":"Qin","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.smim.2025.101955_bib172","article-title":"Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders","author":"Mougiakakos","year":"2024","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib173","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.smim.2025.101955_bib174","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamaneurol.2013.143","article-title":"Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab","volume":"70","author":"Krogias","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.smim.2025.101955_bib175","first-page":"5697670","article-title":"Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies","volume":"2020","author":"Benucci","year":"2020","journal-title":"Case Rep. Neurol. Med"},{"issue":"6","key":"10.1016\/j.smim.2025.101955_bib176","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.braindev.2023.02.003","article-title":"A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure","volume":"45","author":"Jang","year":"2023","journal-title":"Brain Dev."},{"key":"10.1016\/j.smim.2025.101955_bib177","doi-asserted-by":"crossref","first-page":"1437913","DOI":"10.3389\/fneur.2024.1437913","article-title":"Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)","volume":"15","author":"Lee","year":"2024","journal-title":"Front Neurol."},{"issue":"12","key":"10.1016\/j.smim.2025.101955_bib178","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-019-0323-6","article-title":"Chemokines in rheumatic diseases: pathogenic role and therapeutic implications","volume":"15","author":"Miyabe","year":"2019","journal-title":"Nat. Rev. Rheuma"},{"issue":"6726","key":"10.1016\/j.smim.2025.101955_bib179","doi-asserted-by":"crossref","first-page":"eadl4237","DOI":"10.1126\/science.adl4237","article-title":"Programming tissue-sensing T cells that deliver therapies to the brain","volume":"386","author":"Simic","year":"2024","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.smim.2025.101955_bib180","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.cell.2023.10.001","article-title":"Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells","volume":"186","author":"Reincke","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.smim.2025.101955_bib181","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20052036","article-title":"T-independent type II immune responses generate memory B cells","volume":"203","author":"Obukhanych","year":"2006","journal-title":"J. Exp. Med"},{"issue":"17","key":"10.1016\/j.smim.2025.101955_bib182","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1182\/blood-2008-10-185421","article-title":"BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation","volume":"113","author":"Eckl-Dorna","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.smim.2025.101955_bib183","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.imlet.2023.03.003","article-title":"IgD(-)CD27(-) double negative (DN) B cells: origins and functions in health and disease","volume":"255","author":"Beckers","year":"2023","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib184","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/brain\/awac497","article-title":"NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies","volume":"146","author":"Steinke","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.smim.2025.101955_bib185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/ane.13291","article-title":"Efficacy and safety of rituximab in autoimmune encephalitis: a meta-analysis","volume":"142","author":"Nepal","year":"2020","journal-title":"Acta Neurol. Scand."},{"issue":"7","key":"10.1016\/j.smim.2025.101955_bib186","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jamaneurol.2014.463","article-title":"Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy","volume":"71","author":"Irani","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.smim.2025.101955_bib187","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","article-title":"Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis","volume":"88","author":"Scheibe","year":"2017","journal-title":"Neurology"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T15:05:17Z","timestamp":1749222317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532325000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":187,"alternative-id":["S1044532325000272"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2025.101955","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From immunobiology to intervention: Pathophysiology of autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2025.101955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101955"}}